The forecast for prostate malignant neoplasms mortality in Canada from 2024 to 2028 shows a consistent decline in the standardized death rate, starting at 24.4 per 100,000 men in 2024 and decreasing to 22.5 by 2028. The data reflects a year-on-year decrease averaging around 1-2%, demonstrating a positive downward trend in mortality. Over the five-year period, the compound annual growth rate (CAGR) in mortality rates suggests a continuous decline.
Future trends to watch for include advancements in medical treatments and early detection methods, public health initiatives promoting awareness, and potential changes in lifestyle factors among Canadian men that could further impact these rates.
